Skip to content

Clinical trials

Completed Lung Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Status: Completed Country / region: Canada Clear all

59 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20063
20072
20081
20096
20103
20113
20121
20134
20143
20156
20165
20172
20184
20195
20204
20211
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca14
Vertex Pharmaceuticals Incorporated4
Novartis Pharmaceuticals3
University of Alberta3
University of British Columbia3
McMaster University2
University Health Network, Toronto2
University of Washington, the Collaborative Health Studies Coordinating Center2
1QB Information Technologies Inc.1
ActiViews Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases59
Respiratory Tract Diseases24
Asthma15
Bronchial Diseases14
Lung Diseases, Obstructive12
Cystic Fibrosis11
Pulmonary Disease, Chronic Obstructive10
Pathologic Processes8
Genetic Diseases, Inborn6
Lung Neoplasms6

Trials

Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.